Major Limb Outcomes Following Lower Extremity Endovascular Revascularization in Patients With and Without Diabetes Mellitus.
Andrew N Shammas, Haekyung Jeon-Slaughter, Shirling Tsai...
https://pubmed.ncbi.nlm.nih.gov/28440113/Actively Recruiting
Led by Baylor Research Institute · Updated on 2026-02-06
14000
Participants Needed
24
Research Sites
N/A
Total Duration
Researchers are conducting an observational study called XLPAD to evaluate the effectiveness and use of stent and non-stent therapies among patients with peripheral arterial disease PAD. This study aims to create a registry including data from procedures and clinical follow-ups, collecting information from patients treated since January 1, 2005, until 14,000 patients are enrolled. The study focuses on comparing outcomes like need for revascularization, surgical interventions, amputations, and safety events such as death, heart attack, stroke, and procedural complications over 12 months. Patients who receive endovascular interventions involving stents or percutaneous transluminal angioplasty PTA in specific leg arteries, including superficial femoral, popliteal, peroneal, anterior tibial, or posterior tibial arteries, will be included. The study collects detailed background, lesion, intervention, and outcome data into an online system called REDCAP. Follow-up data is gathered at 6 and 12 months after the procedure, but follow-up visits are based on usual clinical care and not mandated by the registry. Treatment decisions, including use of stents or other therapies, remain at the discretion of the care team. Participants contribute by allowing the collection of their medical records, procedural details, and follow-up information. Data collected include patient characteristics, lesion features, treatment details, and clinical outcomes like walking distance and ankle-brachial index changes. Researchers will review events and outcomes up to 12 months post-procedure to assess treatment effectiveness and safety. The registry poses minimal risk since it observes routine care without altering treatments. Total participation duration depends on clinical follow-up timing, typically up to one year after the initial intervention.
CONDITIONS
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
D
David Fernandez Vazquez, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Baylor Research Institute
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Procedure day
Participants undergo an endovascular intervention, receiving either stent(s) or percutaneous transluminal angioplasty (PTA) to specific leg arteries as part of routine care. Data about the procedure and patient background is collected.
1 visit (in-person)
Duration - 6 to 12 months
Participants have clinical visits to monitor their recovery and outcomes, including assessments like Rutherford category, ankle brachial index, and ultrasound.
2 visits (in-person at 6 and 12 months)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Andrew N Shammas, Haekyung Jeon-Slaughter, Shirling Tsai...
https://pubmed.ncbi.nlm.nih.gov/28440113/Ehrin J Armstrong, Haekyung Jeon-Slaughter, Ravi S Kahlon...
https://pubmed.ncbi.nlm.nih.gov/31686573/Subhash Banerjee, Karan Sarode, Atif Mohammad...
https://pubmed.ncbi.nlm.nih.gov/26839391/Subhash Banerjee, Karan Sarode, Apurva Patel...
https://pubmed.ncbi.nlm.nih.gov/25985785/Subhash Banerjee, Rahul Thomas, Karan Sarode...
https://pubmed.ncbi.nlm.nih.gov/25091095/Subhash Banerjee, Haekyung Jeon-Slaughter, Shirling Tsai...
https://pubmed.ncbi.nlm.nih.gov/27832850/Damianos G Kokkinidis, Haekyung Jeon-Slaughter, Houman Khalili...
https://pubmed.ncbi.nlm.nih.gov/29923459/Kunal Patel, Yulun Liu, Farshid Etaee...
https://pubmed.ncbi.nlm.nih.gov/34706553/Subhash Banerjee, Karan Sarode, Thomas Das...
https://pubmed.ncbi.nlm.nih.gov/24754288/Baylor Research Institute
Lead Sponsor